Global Needle-Free Drug Delivery Market 2017-2021

Overview of the global needle-free drug delivery market

According to needle-free drug delivery market outlook, the global needle-free drug delivery market will grow at a CAGR of more than 10% during the forecast period. One of the key drivers that will stimulate the growth of the market in the coming years is the rising demand for the self-administration of drugs. A large number of patients are preferring self-administration of drugs using needle-free delivery devices to reduce healthcare costs. The introduction of self-injectable medications in rheumatoid arthritis encouraged patients to adopt self-administered medications. The influx of patients adopting self-administered medications for this disease increased from 53% to 70% during 2012. This fueled the demand for needle-free drug delivery products among these consumers because they eliminate the risk of needle-stick injuries and cross-contamination. The adoption of the self-administration of drugs using needle-free delivery systems reduces healthcare expenses as it enables patients to receive treatment in non-medical settings. This encourages pharmaceutical companies to come up with new self-administration drugs that can be delivered through needleless injections or devices.

The US is the major revenue contributor towards the needle-free drug delivery market in the Americas. Developed countries such as the US and Canada focus on the development, commercialization, and adoption of needle-free drug delivery devices. Several players operating in the US are investing in research and developmental activities to test new drug applications. The application of these drugs involves needle-free drug delivery devices such as jet injectors, transdermal patches, and other novel needle-free drug technologies.

Competitive landscape and key vendors